Cormorant Asset Management

Latest statistics and disclosures from Cormorant Asset Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Cormorant Asset Management

Companies in the Cormorant Asset Management portfolio as of the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Turning Point Therapeutics I (TPTX) 8.0 $237M +10% 3.0M 78.02
Ishares Tr Russell 2000 Etf Put Option (IWM) 7.8 $229M -50% 1.0M 229.37
Atea Pharmaceuticals (AVIR) 4.7 $138M 6.4M 21.48
Forma Therapeutics Hldgs SHS (FMTX) 4.0 $118M 4.7M 24.89
Bridgebio Pharma (BBIO) 3.9 $115M -13% 1.9M 60.96
Design Therapeutics (DSGN) 3.6 $106M +5% 5.4M 19.57
Revolution Medicines (RVMD) 3.6 $106M +32% 3.3M 31.74
Olema Pharmaceuticals (OLMA) 2.9 $86M -3% 3.1M 27.98
Bioatla (BCAB) 2.8 $83M -10% 2.0M 42.38
Monte Rosa Therapeutics (GLUE) 2.4 $70M NEW 3.2M 21.78
Ark Etf Tr Genomic Rev Etf Put Option (ARKG) 2.4 $69M NEW 750k 92.50
Edgewise Therapeutics (EWTX) 2.3 $67M +34% 3.1M 21.18
Ark Etf Tr Innovation Etf Put Option (ARKK) 2.2 $65M NEW 500k 130.78
Avidity Biosciences Ord (RNA) 1.9 $55M -9% 2.2M 24.71
Apellis Pharmaceuticals (APLS) 1.8 $54M -54% 850k 63.20
Alx Oncology Hldgs (ALXO) 1.7 $49M 890k 54.68
Biomea Fusion (BMEA) 1.6 $48M NEW 3.2M 15.27
Ambrx Biopharma Sponsored Ads (AMAM) 1.6 $47M NEW 2.5M 18.92
Zymeworks (ZYME) 1.6 $46M -33% 1.3M 34.69
Aerovate Therapeutics (AVTE) 1.5 $45M NEW 2.0M 21.97
Prometheus Biosciences (RXDX) 1.5 $45M -11% 1.8M 24.07
Tarsus Pharmaceuticals (TARS) 1.5 $44M -11% 1.5M 28.98
Stoke Therapeutics (STOK) 1.5 $43M -11% 1.3M 33.66
Rocket Pharmaceuticals (RCKT) 1.5 $43M -29% 969k 44.29
Verve Therapeutics (VERV) 1.4 $41M NEW 709k 57.24
Rain Therapeutics (RAIN) 1.3 $40M NEW 2.6M 15.13
Aclaris Therapeutics (ACRS) 1.2 $35M 2.0M 17.56
Omeros Corporation (OMER) 1.1 $33M -48% 2.2M 14.84
Centessa Pharmaceuticals Sponsored Ads (CNTA) 1.1 $31M NEW 1.4M 21.76
Mirati Therapeutics (MRTX) 1.0 $28M -36% 175k 161.53
Y Mabs Therapeutics (YMAB) 0.9 $27M -34% 800k 33.80
Agenus Com New (AGEN) 0.9 $26M -37% 4.8M 5.49
Elevation Oncology (ELEV) 0.9 $26M NEW 2.0M 12.89
Vectivbio Hldg Ord Shs (VECT) 0.9 $26M NEW 2.2M 11.47
Twist Bioscience Corp (TWST) 0.8 $25M 185k 133.25
Reata Pharmaceuticals Cl A (RETA) 0.8 $24M -57% 168k 141.53
Acceleron Pharma (XLRN) 0.7 $22M -36% 175k 125.49
908 Devices (MASS) 0.7 $21M 545k 38.75
Blueprint Medicines (BPMC) 0.7 $21M -3% 238k 87.96
Longboard Pharmaceuticals In (LBPH) 0.7 $21M 2.3M 8.99
Igm Biosciences (IGMS) 0.7 $21M -49% 250k 83.20
Axonics Modulation Technolog (AXNX) 0.7 $20M -53% 322k 63.41
Praxis Precision Medicines I (PRAX) 0.6 $19M -4% 1.0M 18.28
Dermtech Ord ord (DMTK) 0.6 $19M -43% 450k 41.57
Aligos Therapeutics (ALGS) 0.6 $19M -28% 906k 20.39
Talaris Therapeutics (TALS) 0.6 $17M NEW 1.2M 14.20
Akero Therapeutics (AKRO) 0.5 $15M -19% 600k 24.81
Pliant Therapeutics (PLRX) 0.5 $14M -21% 482k 29.12
Cabaletta Bio (CABA) 0.5 $14M -15% 1.6M 8.60
Pharvaris N V (PHVS) 0.5 $14M -13% 745k 18.30
C4 Therapeutics Com Stk (CCCC) 0.5 $13M -85% 355k 37.84
Beam Therapeutics (BEAM) 0.4 $13M -41% 100k 128.71
Connect Biopharma Hldgs Ads (CNTB) 0.4 $13M -35% 650k 19.53
Aptose Biosciences Com New (APTO) 0.4 $13M -4% 3.8M 3.32
Gh Research Ordinary Shares (GHRS) 0.4 $13M NEW 608k 20.64
Myovant Sciences (MYOV) 0.4 $12M -45% 543k 22.77
Repare Therapeutics Ord (RPTX) 0.4 $11M -21% 364k 31.18
Eledon Pharmaceuticals (ELDN) 0.4 $11M 1.4M 7.91
Morphic Hldg (MORF) 0.4 $11M -45% 190k 57.39
Humanigen Com New (HGEN) 0.4 $10M -40% 600k 17.38
Anaptysbio Inc Common (ANAB) 0.3 $10M -40% 385k 25.93
Ascendis Pharma A/s Sponsored Adr (ASND) 0.3 $9.9M -25% 75k 131.55
Zai Lab Adr (ZLAB) 0.3 $9.5M -64% 54k 176.99
Inspire Med Sys (INSP) 0.3 $9.3M -43% 48k 193.26
Bctg Acquisition Corp 0.3 $9.1M 800k 11.37
Galecto (GLTO) 0.3 $8.9M -18% 1.8M 5.06
Tcr2 Therapeutics Inc cs (TCRR) 0.3 $7.9M -46% 480k 16.41
Harpoon Therapeutics (HARP) 0.3 $7.5M -5% 541k 13.87
Catabasis Pharmaceuticals In Com New 0.3 $7.5M NEW 3.6M 2.11
Iteos Therapeutics (ITOS) 0.3 $7.4M -3% 288k 25.65
Silverback Therapeutics (SBTX) 0.3 $7.4M -52% 239k 30.89
Uniqure Nv SHS (QURE) 0.3 $7.4M -4% 240k 30.80
Insmed Com Par $.01 (INSM) 0.2 $7.1M -16% 250k 28.46
Female Health (VERU) 0.2 $6.5M -73% 800k 8.07
Miragen Therapeutics (VRDN) 0.2 $6.3M -25% 343k 18.29
Merus N V (MRUS) 0.2 $6.0M -18% 285k 21.07
Graphite Bio (GRPH) 0.2 $5.9M NEW 203k 29.19
Aveo Pharmaceuticals Com New (AVEO) 0.2 $5.9M -40% 894k 6.59
Deciphera Pharmaceuticals (DCPH) 0.2 $5.3M -27% 144k 36.61
Akouos (AKUS) 0.2 $5.0M -21% 395k 12.55
Sorrento Therapeutics Com New (SRNE) 0.2 $4.8M -81% 500k 9.69
Magenta Therapeutics (MGTA) 0.2 $4.7M -20% 478k 9.78
Helix Acquisition Corp Com Cl A (HLXA) 0.2 $4.4M 430k 10.35
Quotient SHS (QTNT) 0.1 $4.4M -19% 1.2M 3.64
Theravance Biopharma (TBPH) 0.1 $4.4M -45% 300k 14.52
Precision Biosciences Ord (DTIL) 0.1 $4.3M 347k 12.52
5 01 Acquisition Corp Com Cl A (FVAM) 0.1 $4.0M -20% 400k 9.97
Genetron Hldgs Ads (GTH) 0.1 $2.7M -55% 133k 20.14
Autolus Therapeutics Spon Ads (AUTL) 0.1 $2.6M -7% 392k 6.64
Health Sciences Acq Corp 2 Ord Shs (HSAQ) 0.1 $2.4M -70% 240k 10.20
Eiger Biopharmaceuticals (EIGR) 0.1 $2.4M -28% 285k 8.52
Atreca Cl A Com (BCEL) 0.1 $2.3M -6% 274k 8.52
Tricida (TCDA) 0.1 $1.8M 428k 4.32
Gossamer Bio (GOSS) 0.1 $1.6M -76% 198k 8.12
Springworks Therapeutics (SWTX) 0.0 $1.2M -88% 15k 82.40
Orchard Therapeutics Ads (ORTX) 0.0 $1.1M 257k 4.39
X4 Pharmaceuticals (XFOR) 0.0 $676k 104k 6.50
Cardiff Oncology (CRDF) 0.0 $637k -36% 96k 6.65
Minerva Neurosciences (NERV) 0.0 $570k +22% 246k 2.32
Imv (IMV) 0.0 $507k 234k 2.16
Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) 0.0 $278k -85% 19k 14.39
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) 0.0 $217k 83k 2.60
Outlook Therapeutics *w Exp 02/18/202 (OTLKW) 0.0 $130k 417k 0.31

Past Filings by Cormorant Asset Management

SEC 13F filings are viewable for Cormorant Asset Management going back to 2013

View all past filings